Serveur d'exploration sur la glutarédoxine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase.

Identifieur interne : 000358 ( Main/Exploration ); précédent : 000357; suivant : 000359

Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase.

Auteurs : Justin R. Prigge [États-Unis] ; Lucia Coppo [Suède] ; Sebastin S. Martin [Suède] ; Fernando Ogata [Suède] ; Colin G. Miller [États-Unis] ; Michael D. Bruschwein [États-Unis] ; David J. Orlicky [États-Unis] ; Colin T. Shearn [États-Unis] ; Jean A. Kundert [États-Unis] ; Julia Lytchier [Suède] ; Alix E. Herr [États-Unis] ; Se Mattsson [Suède] ; Matthew P. Taylor [États-Unis] ; Tomas N. Gustafsson [Suède] ; Elias S J. Arnér [Suède] ; Arne Holmgren [Suède] ; Edward E. Schmidt [États-Unis]

Source :

RBID : pubmed:28658624

Descripteurs français

English descriptors

Abstract

Energetic nutrients are oxidized to sustain high intracellular NADPH/NADP+ ratios. NADPH-dependent reduction of thioredoxin-1 (Trx1) disulfide and glutathione disulfide by thioredoxin reductase-1 (TrxR1) and glutathione reductase (Gsr), respectively, fuels antioxidant systems and deoxyribonucleotide synthesis. Mouse livers lacking both TrxR1 and Gsr sustain these essential activities using an NADPH-independent methionine-consuming pathway; however, it remains unclear how this reducing power is distributed. Here, we show that liver-specific co-disruption of the genes encoding Trx1, TrxR1, and Gsr (triple-null) causes dramatic hepatocyte hyperproliferation. Thus, even in the absence of Trx1, methionine-fueled glutathione production supports hepatocyte S phase deoxyribonucleotide production. Also, Trx1 in the absence of TrxR1 provides a survival advantage to cells under hyperglycemic stress, suggesting that glutathione, likely via glutaredoxins, can reduce Trx1 disulfide in vivo. In triple-null livers like in many cancers, deoxyribonucleotide synthesis places a critical yet relatively low-volume demand on these reductase systems, thereby favoring high hepatocyte turnover over sustained hepatocyte integrity.

DOI: 10.1016/j.celrep.2017.06.019
PubMed: 28658624
PubMed Central: PMC5730093


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase.</title>
<author>
<name sortKey="Prigge, Justin R" sort="Prigge, Justin R" uniqKey="Prigge J" first="Justin R" last="Prigge">Justin R. Prigge</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Coppo, Lucia" sort="Coppo, Lucia" uniqKey="Coppo L" first="Lucia" last="Coppo">Lucia Coppo</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Martin, Sebastin S" sort="Martin, Sebastin S" uniqKey="Martin S" first="Sebastin S" last="Martin">Sebastin S. Martin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ogata, Fernando" sort="Ogata, Fernando" uniqKey="Ogata F" first="Fernando" last="Ogata">Fernando Ogata</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Miller, Colin G" sort="Miller, Colin G" uniqKey="Miller C" first="Colin G" last="Miller">Colin G. Miller</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bruschwein, Michael D" sort="Bruschwein, Michael D" uniqKey="Bruschwein M" first="Michael D" last="Bruschwein">Michael D. Bruschwein</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Orlicky, David J" sort="Orlicky, David J" uniqKey="Orlicky D" first="David J" last="Orlicky">David J. Orlicky</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Pathology, University of Colorado Anschutz Medical Center, Denver, CO 80045, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology, University of Colorado Anschutz Medical Center, Denver, CO 80045</wicri:regionArea>
<placeName>
<region type="state">Colorado</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Shearn, Colin T" sort="Shearn, Colin T" uniqKey="Shearn C" first="Colin T" last="Shearn">Colin T. Shearn</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Center, Denver, CO 80045, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Center, Denver, CO 80045</wicri:regionArea>
<placeName>
<region type="state">Colorado</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kundert, Jean A" sort="Kundert, Jean A" uniqKey="Kundert J" first="Jean A" last="Kundert">Jean A. Kundert</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lytchier, Julia" sort="Lytchier, Julia" uniqKey="Lytchier J" first="Julia" last="Lytchier">Julia Lytchier</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Herr, Alix E" sort="Herr, Alix E" uniqKey="Herr A" first="Alix E" last="Herr">Alix E. Herr</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mattsson, Se" sort="Mattsson, Se" uniqKey="Mattsson " first=" Se" last="Mattsson"> Se Mattsson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Taylor, Matthew P" sort="Taylor, Matthew P" uniqKey="Taylor M" first="Matthew P" last="Taylor">Matthew P. Taylor</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gustafsson, Tomas N" sort="Gustafsson, Tomas N" uniqKey="Gustafsson T" first="Tomas N" last="Gustafsson">Tomas N. Gustafsson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden; Department of Clinical Microbiology, Clinical Bacteriology, Sunderby Research Unit, Umeå University, 901 85 Umeå, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden; Department of Clinical Microbiology, Clinical Bacteriology, Sunderby Research Unit, Umeå University, 901 85 Umeå</wicri:regionArea>
<wicri:noRegion>901 85 Umeå</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Arner, Elias S J" sort="Arner, Elias S J" uniqKey="Arner E" first="Elias S J" last="Arnér">Elias S J. Arnér</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Holmgren, Arne" sort="Holmgren, Arne" uniqKey="Holmgren A" first="Arne" last="Holmgren">Arne Holmgren</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schmidt, Edward E" sort="Schmidt, Edward E" uniqKey="Schmidt E" first="Edward E" last="Schmidt">Edward E. Schmidt</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA. Electronic address: eschmidt@montana.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28658624</idno>
<idno type="pmid">28658624</idno>
<idno type="doi">10.1016/j.celrep.2017.06.019</idno>
<idno type="pmc">PMC5730093</idno>
<idno type="wicri:Area/Main/Corpus">000328</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000328</idno>
<idno type="wicri:Area/Main/Curation">000328</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000328</idno>
<idno type="wicri:Area/Main/Exploration">000328</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase.</title>
<author>
<name sortKey="Prigge, Justin R" sort="Prigge, Justin R" uniqKey="Prigge J" first="Justin R" last="Prigge">Justin R. Prigge</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Coppo, Lucia" sort="Coppo, Lucia" uniqKey="Coppo L" first="Lucia" last="Coppo">Lucia Coppo</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Martin, Sebastin S" sort="Martin, Sebastin S" uniqKey="Martin S" first="Sebastin S" last="Martin">Sebastin S. Martin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ogata, Fernando" sort="Ogata, Fernando" uniqKey="Ogata F" first="Fernando" last="Ogata">Fernando Ogata</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Miller, Colin G" sort="Miller, Colin G" uniqKey="Miller C" first="Colin G" last="Miller">Colin G. Miller</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bruschwein, Michael D" sort="Bruschwein, Michael D" uniqKey="Bruschwein M" first="Michael D" last="Bruschwein">Michael D. Bruschwein</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Orlicky, David J" sort="Orlicky, David J" uniqKey="Orlicky D" first="David J" last="Orlicky">David J. Orlicky</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Pathology, University of Colorado Anschutz Medical Center, Denver, CO 80045, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology, University of Colorado Anschutz Medical Center, Denver, CO 80045</wicri:regionArea>
<placeName>
<region type="state">Colorado</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Shearn, Colin T" sort="Shearn, Colin T" uniqKey="Shearn C" first="Colin T" last="Shearn">Colin T. Shearn</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Center, Denver, CO 80045, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Center, Denver, CO 80045</wicri:regionArea>
<placeName>
<region type="state">Colorado</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kundert, Jean A" sort="Kundert, Jean A" uniqKey="Kundert J" first="Jean A" last="Kundert">Jean A. Kundert</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lytchier, Julia" sort="Lytchier, Julia" uniqKey="Lytchier J" first="Julia" last="Lytchier">Julia Lytchier</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Herr, Alix E" sort="Herr, Alix E" uniqKey="Herr A" first="Alix E" last="Herr">Alix E. Herr</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mattsson, Se" sort="Mattsson, Se" uniqKey="Mattsson " first=" Se" last="Mattsson"> Se Mattsson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Taylor, Matthew P" sort="Taylor, Matthew P" uniqKey="Taylor M" first="Matthew P" last="Taylor">Matthew P. Taylor</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gustafsson, Tomas N" sort="Gustafsson, Tomas N" uniqKey="Gustafsson T" first="Tomas N" last="Gustafsson">Tomas N. Gustafsson</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden; Department of Clinical Microbiology, Clinical Bacteriology, Sunderby Research Unit, Umeå University, 901 85 Umeå, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden; Department of Clinical Microbiology, Clinical Bacteriology, Sunderby Research Unit, Umeå University, 901 85 Umeå</wicri:regionArea>
<wicri:noRegion>901 85 Umeå</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Arner, Elias S J" sort="Arner, Elias S J" uniqKey="Arner E" first="Elias S J" last="Arnér">Elias S J. Arnér</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Holmgren, Arne" sort="Holmgren, Arne" uniqKey="Holmgren A" first="Arne" last="Holmgren">Arne Holmgren</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm</wicri:regionArea>
<wicri:noRegion>171 77 Stockholm</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Schmidt, Edward E" sort="Schmidt, Edward E" uniqKey="Schmidt E" first="Edward E" last="Schmidt">Edward E. Schmidt</name>
<affiliation wicri:level="2">
<nlm:affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA. Electronic address: eschmidt@montana.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Microbiology & Immunology, Montana State University, Bozeman, MT 59718</wicri:regionArea>
<placeName>
<region type="state">Montana</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Cell reports</title>
<idno type="eISSN">2211-1247</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals (MeSH)</term>
<term>Cell Proliferation (physiology)</term>
<term>Glutathione Reductase (metabolism)</term>
<term>Hepatocytes (cytology)</term>
<term>Hepatocytes (metabolism)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Mice (MeSH)</term>
<term>Thioredoxin Reductase 1 (metabolism)</term>
<term>Thioredoxins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux (MeSH)</term>
<term>Glutathione reductase (métabolisme)</term>
<term>Humains (MeSH)</term>
<term>Hépatocytes (cytologie)</term>
<term>Hépatocytes (métabolisme)</term>
<term>Mâle (MeSH)</term>
<term>Prolifération cellulaire (physiologie)</term>
<term>Souris (MeSH)</term>
<term>Thioredoxin reductase 1 (métabolisme)</term>
<term>Thiorédoxines (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Glutathione Reductase</term>
<term>Thioredoxin Reductase 1</term>
<term>Thioredoxins</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr">
<term>Hépatocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Hepatocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Hepatocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Glutathione reductase</term>
<term>Hépatocytes</term>
<term>Thioredoxin reductase 1</term>
<term>Thiorédoxines</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Prolifération cellulaire</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Cell Proliferation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Humans</term>
<term>Male</term>
<term>Mice</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Humains</term>
<term>Mâle</term>
<term>Souris</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Energetic nutrients are oxidized to sustain high intracellular NADPH/NADP
<sup>+</sup>
ratios. NADPH-dependent reduction of thioredoxin-1 (Trx1) disulfide and glutathione disulfide by thioredoxin reductase-1 (TrxR1) and glutathione reductase (Gsr), respectively, fuels antioxidant systems and deoxyribonucleotide synthesis. Mouse livers lacking both TrxR1 and Gsr sustain these essential activities using an NADPH-independent methionine-consuming pathway; however, it remains unclear how this reducing power is distributed. Here, we show that liver-specific co-disruption of the genes encoding Trx1, TrxR1, and Gsr (triple-null) causes dramatic hepatocyte hyperproliferation. Thus, even in the absence of Trx1, methionine-fueled glutathione production supports hepatocyte S phase deoxyribonucleotide production. Also, Trx1 in the absence of TrxR1 provides a survival advantage to cells under hyperglycemic stress, suggesting that glutathione, likely via glutaredoxins, can reduce Trx1 disulfide in vivo. In triple-null livers like in many cancers, deoxyribonucleotide synthesis places a critical yet relatively low-volume demand on these reductase systems, thereby favoring high hepatocyte turnover over sustained hepatocyte integrity.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">28658624</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>04</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2211-1247</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>19</Volume>
<Issue>13</Issue>
<PubDate>
<Year>2017</Year>
<Month>06</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>Cell reports</Title>
<ISOAbbreviation>Cell Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase.</ArticleTitle>
<Pagination>
<MedlinePgn>2771-2781</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S2211-1247(17)30816-1</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2017.06.019</ELocationID>
<Abstract>
<AbstractText>Energetic nutrients are oxidized to sustain high intracellular NADPH/NADP
<sup>+</sup>
ratios. NADPH-dependent reduction of thioredoxin-1 (Trx1) disulfide and glutathione disulfide by thioredoxin reductase-1 (TrxR1) and glutathione reductase (Gsr), respectively, fuels antioxidant systems and deoxyribonucleotide synthesis. Mouse livers lacking both TrxR1 and Gsr sustain these essential activities using an NADPH-independent methionine-consuming pathway; however, it remains unclear how this reducing power is distributed. Here, we show that liver-specific co-disruption of the genes encoding Trx1, TrxR1, and Gsr (triple-null) causes dramatic hepatocyte hyperproliferation. Thus, even in the absence of Trx1, methionine-fueled glutathione production supports hepatocyte S phase deoxyribonucleotide production. Also, Trx1 in the absence of TrxR1 provides a survival advantage to cells under hyperglycemic stress, suggesting that glutathione, likely via glutaredoxins, can reduce Trx1 disulfide in vivo. In triple-null livers like in many cancers, deoxyribonucleotide synthesis places a critical yet relatively low-volume demand on these reductase systems, thereby favoring high hepatocyte turnover over sustained hepatocyte integrity.</AbstractText>
<CopyrightInformation>Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Prigge</LastName>
<ForeName>Justin R</ForeName>
<Initials>JR</Initials>
<AffiliationInfo>
<Affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Coppo</LastName>
<ForeName>Lucia</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martin</LastName>
<ForeName>Sebastin S</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ogata</LastName>
<ForeName>Fernando</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Miller</LastName>
<ForeName>Colin G</ForeName>
<Initials>CG</Initials>
<AffiliationInfo>
<Affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bruschwein</LastName>
<ForeName>Michael D</ForeName>
<Initials>MD</Initials>
<AffiliationInfo>
<Affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Orlicky</LastName>
<ForeName>David J</ForeName>
<Initials>DJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, University of Colorado Anschutz Medical Center, Denver, CO 80045, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shearn</LastName>
<ForeName>Colin T</ForeName>
<Initials>CT</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Center, Denver, CO 80045, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kundert</LastName>
<ForeName>Jean A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lytchier</LastName>
<ForeName>Julia</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herr</LastName>
<ForeName>Alix E</ForeName>
<Initials>AE</Initials>
<AffiliationInfo>
<Affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mattsson</LastName>
<ForeName>Åse</ForeName>
<Initials>Å</Initials>
<AffiliationInfo>
<Affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>Matthew P</ForeName>
<Initials>MP</Initials>
<AffiliationInfo>
<Affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Gustafsson</LastName>
<ForeName>Tomas N</ForeName>
<Initials>TN</Initials>
<AffiliationInfo>
<Affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden; Department of Clinical Microbiology, Clinical Bacteriology, Sunderby Research Unit, Umeå University, 901 85 Umeå, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Arnér</LastName>
<ForeName>Elias S J</ForeName>
<Initials>ESJ</Initials>
<AffiliationInfo>
<Affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Holmgren</LastName>
<ForeName>Arne</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Division of Biochemistry, Medical Biochemistry & Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Schmidt</LastName>
<ForeName>Edward E</ForeName>
<Initials>EE</Initials>
<AffiliationInfo>
<Affiliation>Microbiology & Immunology, Montana State University, Bozeman, MT 59718, USA. Electronic address: eschmidt@montana.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P30 DK048520</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 GM110732</GrantID>
<Acronym>GM</Acronym>
<Agency>NIGMS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R21 AG055022</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P30 DK079626</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AG040020</GrantID>
<Acronym>AG</Acronym>
<Agency>NIA NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>P60 DK079626</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI055739</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Cell Rep</MedlineTA>
<NlmUniqueID>101573691</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>52500-60-4</RegistryNumber>
<NameOfSubstance UI="D013879">Thioredoxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.8.1.7</RegistryNumber>
<NameOfSubstance UI="D005980">Glutathione Reductase</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.8.1.9</RegistryNumber>
<NameOfSubstance UI="D054481">Thioredoxin Reductase 1</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005980" MajorTopicYN="N">Glutathione Reductase</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D054481" MajorTopicYN="N">Thioredoxin Reductase 1</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013879" MajorTopicYN="N">Thioredoxins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">cancer</Keyword>
<Keyword MajorTopicYN="Y">glutathione</Keyword>
<Keyword MajorTopicYN="Y">liver</Keyword>
<Keyword MajorTopicYN="Y">methionine cycle</Keyword>
<Keyword MajorTopicYN="Y">mouse model</Keyword>
<Keyword MajorTopicYN="Y">proliferation</Keyword>
<Keyword MajorTopicYN="Y">redox</Keyword>
<Keyword MajorTopicYN="Y">ribonucleotide reductase</Keyword>
<Keyword MajorTopicYN="Y">thioredoxin</Keyword>
<Keyword MajorTopicYN="Y">transsulfuration</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2016</Year>
<Month>12</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2017</Year>
<Month>05</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>06</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>6</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>6</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>4</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">28658624</ArticleId>
<ArticleId IdType="pii">S2211-1247(17)30816-1</ArticleId>
<ArticleId IdType="doi">10.1016/j.celrep.2017.06.019</ArticleId>
<ArticleId IdType="pmc">PMC5730093</ArticleId>
<ArticleId IdType="mid">NIHMS884918</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Free Radic Biol Med. 2010 Dec 1;49(11):1617-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20851762</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Cell Biol. 2005 Mar;25(5):1980-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15713651</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Free Radic Biol Med. 2013 Oct;63:369-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23743293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta. 2009 Jun;1790(6):495-526</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19364476</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Free Radic Biol Med. 2016 Jun;95:27-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26923386</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Biochem. 1985;54:237-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3896121</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Carcinogenesis. 1993 Sep;14(9):1825-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8403205</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Chem Biol. 2015 Jan;11(1):64-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25402766</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1964 Oct;239:3436-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14245400</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Liver Dis. 2004 Feb;24(1):21-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15085484</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2006 Jun 2;281(22):15058-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16574642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2011 May 10;108(19):7991-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21521794</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochim Biophys Acta. 2013 May;1830(5):3289-303</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23201771</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2001 Jan 26;291(5504):643-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11158675</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Death Dis. 2014 May 22;5:e1235</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24853413</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2004 Feb 27;279(9):7537-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14676218</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antioxid Redox Signal. 2014 Aug 10;21(5):669-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24295294</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochemistry. 2000 Oct 24;39(42):13005-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11041866</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Diagn Pathol. 2006 Aug-Nov;23(3-4):149-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17355088</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Free Radic Biol Med. 2004 Sep 15;37(6):755-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15304252</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Biochem Biophys. 2016 Apr 1;595:64-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27095218</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Gastrointest Liver Physiol. 2003 Jan;284(1):G15-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12488232</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2016 Apr 28;11(4):e0154152</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27124661</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Biochem. 2000 Oct;267(20):6102-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11012661</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dev Biol. 1996 Aug 25;178(1):179-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8812119</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Free Radic Biol Med. 2007 Apr 1;42(7):1008-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17349928</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gerontol A Biol Sci Med Sci. 2013 Sep;68(9):1023-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23403066</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2015 Mar 2;125(3):981-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25621497</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2010 Nov 15;70(22):9505-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21045148</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Free Radic Biol Med. 2007 Sep 15;43(6):911-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17697936</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Biochem. 1979;48:133-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">382982</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Toxicol Pathol. 2015 Jun;43(4):546-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25326589</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Free Radic Biol Med. 2012 Feb 15;52(4):803-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22198266</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4882-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9560197</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2015 Mar 20;6:6479</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25790857</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Protein Sci. 2003 Feb;12(2):372-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12538901</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2009 Jul 07;4(7):e6158</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19584930</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Ther. 1995;67(2):155-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7494863</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Suède</li>
<li>États-Unis</li>
</country>
<region>
<li>Colorado</li>
<li>Montana</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Montana">
<name sortKey="Prigge, Justin R" sort="Prigge, Justin R" uniqKey="Prigge J" first="Justin R" last="Prigge">Justin R. Prigge</name>
</region>
<name sortKey="Bruschwein, Michael D" sort="Bruschwein, Michael D" uniqKey="Bruschwein M" first="Michael D" last="Bruschwein">Michael D. Bruschwein</name>
<name sortKey="Herr, Alix E" sort="Herr, Alix E" uniqKey="Herr A" first="Alix E" last="Herr">Alix E. Herr</name>
<name sortKey="Kundert, Jean A" sort="Kundert, Jean A" uniqKey="Kundert J" first="Jean A" last="Kundert">Jean A. Kundert</name>
<name sortKey="Miller, Colin G" sort="Miller, Colin G" uniqKey="Miller C" first="Colin G" last="Miller">Colin G. Miller</name>
<name sortKey="Orlicky, David J" sort="Orlicky, David J" uniqKey="Orlicky D" first="David J" last="Orlicky">David J. Orlicky</name>
<name sortKey="Schmidt, Edward E" sort="Schmidt, Edward E" uniqKey="Schmidt E" first="Edward E" last="Schmidt">Edward E. Schmidt</name>
<name sortKey="Shearn, Colin T" sort="Shearn, Colin T" uniqKey="Shearn C" first="Colin T" last="Shearn">Colin T. Shearn</name>
<name sortKey="Taylor, Matthew P" sort="Taylor, Matthew P" uniqKey="Taylor M" first="Matthew P" last="Taylor">Matthew P. Taylor</name>
</country>
<country name="Suède">
<noRegion>
<name sortKey="Coppo, Lucia" sort="Coppo, Lucia" uniqKey="Coppo L" first="Lucia" last="Coppo">Lucia Coppo</name>
</noRegion>
<name sortKey="Arner, Elias S J" sort="Arner, Elias S J" uniqKey="Arner E" first="Elias S J" last="Arnér">Elias S J. Arnér</name>
<name sortKey="Gustafsson, Tomas N" sort="Gustafsson, Tomas N" uniqKey="Gustafsson T" first="Tomas N" last="Gustafsson">Tomas N. Gustafsson</name>
<name sortKey="Holmgren, Arne" sort="Holmgren, Arne" uniqKey="Holmgren A" first="Arne" last="Holmgren">Arne Holmgren</name>
<name sortKey="Lytchier, Julia" sort="Lytchier, Julia" uniqKey="Lytchier J" first="Julia" last="Lytchier">Julia Lytchier</name>
<name sortKey="Martin, Sebastin S" sort="Martin, Sebastin S" uniqKey="Martin S" first="Sebastin S" last="Martin">Sebastin S. Martin</name>
<name sortKey="Mattsson, Se" sort="Mattsson, Se" uniqKey="Mattsson " first=" Se" last="Mattsson"> Se Mattsson</name>
<name sortKey="Ogata, Fernando" sort="Ogata, Fernando" uniqKey="Ogata F" first="Fernando" last="Ogata">Fernando Ogata</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/GlutaredoxinV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000358 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000358 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    GlutaredoxinV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28658624
   |texte=   Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28658624" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GlutaredoxinV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 15:13:42 2020. Site generation: Wed Nov 18 15:16:12 2020